Interestingly, based on the idea that DHHC recognize their substrate by amino acid sequence, a competitive polypeptide is designed towards more inhibition specificity for PD-L1 than the commonly used universal palmitoylation inhibitor 2-BP, indeed the expression of PD-L1 was reduced by this inhibitor in tumor cells (81). The gene discussed is CD274; the disease is neoplasm.